MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma
Publication information:
Issa H, Fléchon L, Laine W, Ouelkdite A, Gaggero S, Cozzani A, Tilmont R, Chauvet P, Gower N, Sklavenitis-Pistofidis R, Brinster C, Thuru X, Touil Y, Quesnel B, Mitra S, Ghobrial I, Kluza J, Manier S. MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma.
iScience. 2024;27(4):109417.